Skip to main content

Table 1 Number and crude percentages of detected second tumors

From: Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors

Incidence of second tumors

Technique

Total

2526 (%)

3D-CRT

538 (%)

IMRT

1719 (%)

VMAT

269 (%)

No

515 (95.7)

1660 (96.6)

259 (96.3)

2434 (96.4)

Pelvis

 Bladder

8 (1.5)

19 (1.1)

4 (1.5)

31 (1.2)

 Rectum

0 (0.0)

4 (0.2)

1 (0.4)

5 (0.2)

 Sigma

0 (0.0)

2 (0.1)

0 (0.0)

2 (0.1)

Abdomen

 Colon

0 (0.0)

4 (0.2)

1 (0.4)

5 (0.2)

 Stomach

0 (0.0)

4 (0.2)

1 (0.4)

5 (0.2)

 Kidney

2 (0.4)

1 (0.1)

0 (0.0)

3 (0.1)

 Pancreas

2 (0.4)

0 (0.0)

0 (0.0)

2 (0.1)

 Small bowel (duodenal)

1 (0.2)

0 (0.0)

0 (0.0)

1 (0.0)

 Small bowel (ileum)

0 (0.0)

1 (0.1)

0 (0.0)

1 (0.0)

Other sites

 Lung

4 (0.7)

6 (0.3)

2 (0.7)

12 (0.5)

 Melanoma

1 (0.2)

7 (0.4)

0 (0.0)

8 (0.3)

 Skin

0 (0.0)

6 (0.3)

0 (0.0)

6 (0.2)

 Head and neck

2 (0.4)

2 (0.1)

0 (0.0)

4 (0.2)

 Brain

0 (0.0)

3 (0.2)

0 (0.0)

3 (0.1)

 Lymphoma

0 (0.0)

0 (0.0)

1 (0.4)

1 (0.0)

 Leukaemia

1 (0.0)

0 (0.0)

0 (0.0)

1 (0.0)

 Oesophagus

1 (0.2)

0 (0.0)

0 (0.0)

1 (0.0)

 Lip

1 (0.2)

0 (0.0)

0 (0.0)

1 (0.0)

  1. Legend: 3D-CRT three-dimensional conformal radiotherapy; IMRT Intensity modulated radiotherapy, VMAT volumetric modulated radiotherapy